Silicon Sensor International AG today received medical product certification for the license of the third generation of its tumor sensor for all markets within the European Union. Through the combination of gamma and PET diagnostics, the sensor enables not only direct identification and analysis of cancer, but also the identification of lymph nodes affected by cancer cells. It is used in surgical procedures.
With the tumor sensor, Silicon Sensor has a licensed medical product that meets the latest requirements in terms of technical and ergonomic design and sets itself apart in the market with its unique selling points. The product was developed exclusively in-house and is characterized by extremely precise tumor location that has never been achieved before.
The development of its own sensor systems for medical applications is an important aspect of Silicon Sensor's corporate strategy. The life-science market in particular presents numerous further possibilities for developing innovative sensor systems thanks to the core competencies and experience of the Silicon Sensor Group. In the case of the tumor sensor, the entire value- added chain will be carried out in-house - from development of the sensor component and sensor module through to product design and production of the complete sensor system. This safeguards high product quality and the achievement of a very good profit margin. Marketing of the tumor sensor is scheduled to commence in fall 2011.
Further information about the Silicon Sensor Group can be found on our website www.silicon-sensor.com or at +49 30 639923-710.
Silicon Sensor International AG
Board of Directors
In a few steps quickly and conveniently to the right product.
Please search by complete product numbers, e.g. CTE7005GY4 or 501430. In order to increase the number of search results, please search by part of the product number only, e.g. CTE7.